Crossref
The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review
Translational Breast Cancer Research · 2021-01 · 2 · 6-6
DOI: 10.21037/tbcr-20-66 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Breast Cancer Research, 2021-01. Verfasst von Jing He und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
He, J., & Jia, Y. (2021). The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review. Translational Breast Cancer Research, 2, 6-6. https://doi.org/10.21037/tbcr-20-66
Vancouver
He J, Jia Y. The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review. Translational Breast Cancer Research. 2021;2:6-6. doi:10.21037/tbcr-20-66
BibTeX
@article{He2021,
author = {He, Jing and Jia, Yijun},
title = {The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review},
journal = {Translational Breast Cancer Research},
year = {2021},
volume = {2},
pages = {6--6},
doi = {10.21037/tbcr-20-66}
}
EUVIMED